SHR8058

· Jiangsu HengRui Medicine Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SHR8058, covering 2022-08-25 to 2022-08-25. Get the full timeline:

Most recent: Clinical Trial Update: Effect of SHR8058 on Signs and Symptoms of Dry Eye Disease Associated With Meibomian Gland Dysfunction [Phase 3]